{rfName}
KR

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Teruel, IAuthorFerrando, AAuthorPlaja, AAuthorLopez, EAuthor

Share

October 31, 2019
Publications
>
Meeting Abstract
No

KRAS mutations (KRAS-mut) and antiPD1/PDL1 therapy in a cohort of non-small cell lung cancer (NSCLC) patients (p): Experience from a single institution

Publicated to:Annals Of Oncology. 28 - 2017-09-01 28(), DOI:

Authors: Lecuona, CE; Bueno, MTM; Vila, L; Teruel, I; Angelats, L; Ferrando, A; Plaja, A; Torres, P; Lopez, E; Muriel, R; Munoz-Marmol, AM; Mate, JL; Velarde, JM; Costa, EC

Affiliations

Fundacio Inst Invest Ciencies Salut Germans Trias, Hosp Univ Germans Trias & Pujol, Catalan Inst Oncol Badalona, Biostat, Badalona, Spain - Author
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol Badalona, Med Oncol & Hematol, Badalona, Spain - Author
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol Badalona, Med Oncol, Badalona, Spain - Author
Hosp Badalona Germans Trias & Pujol, Pathol, Badalona, Spain - Author

Abstract

Keywords

Ciências biológicas iCiências biológicas iiiFarmaciaGeneral medicineHematologyMedicina iMedicina iiMedicina iiiMedicine (miscellaneous)NutriçãoOncologySaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Annals Of Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2017, it was in position 9/223, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Lecuona, CE) and Last Author (Costa, EC).